UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 9.927

Sortiert nach

Investigational new insulin glargine 300 U/ml has the same metabolism as insulin glargine 100 U/ml

Diabetes, obesity & metabolism, 2014-09, Vol.16 (9), p.873-876

2014

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic and glucodynamic variability : assessment of insulin glargine, NPH insulin and insulin ultralente in healthy volunteers using a euglycaemic clamp technique

Diabetologia, 2005-10, Vol.48 (10), p.1988-1995

2005

Link zum Volltext

Verfügbarkeit prüfen

Low within- and between-day variability in exposure to new insulin glargine 300 U/ml

Diabetes, obesity & metabolism, 2015-03, Vol.17 (3), p.261-267

2015

Link zum Volltext

Verfügbarkeit prüfen

Insulin glulisine, a new rapid-acting insulin analogue, displays a rapid time-action profile in obese non-diabetic subjects

Experimental and clinical endocrinology & diabetes, 2005-09, Vol.113 (8), p.435

2005

Link zum Volltext

Verfügbarkeit prüfen

Single-dose new insulin glargine 300 U/ml provides prolonged, stable glycaemic control in Japanese and European people with type 1 diabetes

Diabetes, obesity & metabolism, 2015-03, Vol.17 (3), p.254-260

2015

Link zum Volltext

Verfügbarkeit prüfen

A comparison of the steady-state pharmacokinetics and pharmacodynamics of a novel rapid-acting insulin analog, insulin glulisine, and regular human insulin in healthy volunteers using the euglycemic clamp technique

Experimental and clinical endocrinology & diabetes, 2005-05, Vol.113 (5), p.292

2005

Link zum Volltext

Verfügbarkeit prüfen

Equipotency of insulin glargine and regular human insulin on glucose disposal in healthy subjects following intravenous infusion

Acta diabetologica, 2003-12, Vol.40 (4), p.156-162

2003

Link zum Volltext

Verfügbarkeit prüfen

Lixisenatide resensitizes the insulin-secretory response to intravenous glucose challenge in people with type 2 diabetes - a study in both people with type 2 diabetes and healthy subjects

Diabetes, obesity & metabolism, 2014-09, Vol.16 (9), p.793-800

2014

Link zum Volltext

Verfügbarkeit prüfen

Insulin glulisine: a faster onset of action compared with insulin lispro

Diabetes, obesity & metabolism, 2007-09, Vol.9 (5), p.746-753

2007

Link zum Volltext

Verfügbarkeit prüfen

Preservation of Endothelial Function by Ramipril in Rabbits on a Long-Term Atherogenic Diet

Journal of cardiovascular pharmacology, 1991, Vol.18 Suppl 2, p.S110-S115

1991

Link zum Volltext

Verfügbarkeit prüfen

A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes

Experimental and clinical endocrinology & diabetes, 2008-05, Vol.116 (5), p.282

2008

Link zum Volltext

Verfügbarkeit prüfen

Fluctuation and reproducibility of exposure and effect of insulin glargine in healthy subjects

Diabetes, obesity & metabolism, 2008-11, Vol.10 (11), p.1105-1113

2008

Link zum Volltext

Verfügbarkeit prüfen

Single-dose new insulin glargine 300U/ml provides prolonged, stable glycaemic control in Japanese and European people with type 1 diabetes

Diabetes, obesity & metabolism, 2015-03, Vol.17 (3), p.254-260

2015

Link zum Volltext

Verfügbarkeit prüfen

Low-Dose Felodipine Treatment Attenuates Endothelial Dysfunction in Rabbits Fed an Atherogenic Diet

Journal of cardiovascular pharmacology, 1991, Vol.18 Suppl 10, p.S36-S41

1991

Link zum Volltext

Verfügbarkeit prüfen

Single‐dose new insulin glargine 300 U/ml provides prolonged, stable glycaemic control in J apanese and E uropean people with type 1 diabetes

Diabetes, obesity & metabolism, 2015-03, Vol.17 (3), p.254-260

2015

Link zum Volltext

Verfügbarkeit prüfen

Long-term ACE inhibition doubles lifespan of hypertensive rats

Circulation (New York, N.Y.), 1997-11, Vol.96 (9), p.3164-3172

1997

Link zum Volltext

Verfügbarkeit prüfen

Late Treatment With Ramipril Increases Survival in Old Spontaneously Hypertensive Rats

Hypertension (Dallas, Tex. 1979), 1999-08, Vol.34 (2), p.291-295

1999

Link zum Volltext

Verfügbarkeit prüfen

Dose-response relationship of insulin glulisine in subjects with type 1 diabetes

Diabetes, obesity & metabolism, 2009, Vol.11 (1), p.60-68

2009

Link zum Volltext

Verfügbarkeit prüfen

Loop Diuretics Combined with an ACE Inhibitor for Treatment of Hypertension: A Study with Furosemide, Piretanide, and Ramipril in Spontaneously Hypertensive Rats

Journal of cardiovascular pharmacology, 1989, Vol.13 Suppl 3, p.S35-S39

1989

Link zum Volltext

Verfügbarkeit prüfen

Preservation of Endothelial Function by Ramipril in Rabbits on a Long-Term Atherogenic Diet

Journal of cardiovascular pharmacology, 1991, Vol.18 Suppl 2, p.S110-S115

1991

Link zum Volltext

Verfügbarkeit prüfen

CE Inhibition and Natriuresis with Ramipril in Conscious SHR: Different Modes of Action of Loop and Thiazide Diuretics

Journal of cardiovascular pharmacology, 1987, Vol.10 Suppl 7, p.141-144

1987

Link zum Volltext

Verfügbarkeit prüfen

Nephroprotection by long-term ACE inhibition with ramipril in spontaneously hypertensive stroke prone rats

Kidney international, 1998-12, Vol.54 (6), p.2037-2044

1998

Link zum Volltext

Verfügbarkeit prüfen

High-Affinity Binding of the Converting Enzyme Inhibitor, Ramiprilat, to Isolated Human Glomeruli

Journal of cardiovascular pharmacology, 1989, Vol.13 Suppl 3, p.S31-S34

1989

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of once weekly subcutaneous idrabiotaparinux in the treatment of patients with symptomatic deep venous thrombosis

Journal of thrombosis and haemostasis, 2011-01, Vol.9 (1), p.92-99

Equinox Investigators

2011

Link zum Volltext

Verfügbarkeit prüfen

Sustained Diurnal Blood Pressure Reduction in SHR with Ramipril Assessed by Telemetric Monitoring

Clinical and experimental hypertension (1993), 1997, Vol.19 (8), p.1233-1246

1997

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 9.927

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(8.242)
Mit Volltextzugriff
(8.701)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

7 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Free E-Journals
(4.324)
IngentaConnect
(4.137)
MEDLINE
(3.782)
Journals@Ovid Ovid Full Text
(2.419)
Single Journals
(2.344)
Elsevier ScienceDirect Journals Complete
(2.167)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.780)
IngentaConnect Journals
(1.654)
SpringerLink (Online service)
(1.344)
Wiley Online Library - AutoHoldings Journals
(1.049)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(728)
Wiley Online Library Full Collection 2018
(709)
APS: American Physical Society E-Journals (Physics)
(553)
PROLA - Physical Review Online Archive
(534)
Oxford Journals
(436)
eBooks on EBSCOhost
(328)
JSTOR
(296)
Oxford Journals 2020 Medicine
(295)
Ebook Central Perpetual and DDA
(273)
Nature
(258)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Investigational new insulin glargine 300 U/ml has the same metabolism as insulin glargine 100 U/ml

Pharmacokinetic and glucodynamic variability : assessment of insulin glargine, NPH insulin and insulin ultralente in healthy volunteers using a euglycaemic clamp technique

Low within- and between-day variability in exposure to new insulin glargine 300 U/ml

Insulin glulisine, a new rapid-acting insulin analogue, displays a rapid time-action profile in obese non-diabetic subjects

Single-dose new insulin glargine 300 U/ml provides prolonged, stable glycaemic control in Japanese and European people with type 1 diabetes

A comparison of the steady-state pharmacokinetics and pharmacodynamics of a novel rapid-acting insulin analog, insulin glulisine, and regular human insulin in healthy volunteers using the euglycemic clamp technique

Equipotency of insulin glargine and regular human insulin on glucose disposal in healthy subjects following intravenous infusion

Lixisenatide resensitizes the insulin-secretory response to intravenous glucose challenge in people with type 2 diabetes - a study in both people with type 2 diabetes and healthy subjects

Insulin glulisine: a faster onset of action compared with insulin lispro

Preservation of Endothelial Function by Ramipril in Rabbits on a Long-Term Atherogenic Diet

A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes

Fluctuation and reproducibility of exposure and effect of insulin glargine in healthy subjects

Single-dose new insulin glargine 300U/ml provides prolonged, stable glycaemic control in Japanese and European people with type 1 diabetes

Low-Dose Felodipine Treatment Attenuates Endothelial Dysfunction in Rabbits Fed an Atherogenic Diet

Single‐dose new insulin glargine 300 U/ml provides prolonged, stable glycaemic control in J apanese and E uropean people with type 1 diabetes

Long-term ACE inhibition doubles lifespan of hypertensive rats

Late Treatment With Ramipril Increases Survival in Old Spontaneously Hypertensive Rats

Dose-response relationship of insulin glulisine in subjects with type 1 diabetes

Loop Diuretics Combined with an ACE Inhibitor for Treatment of Hypertension: A Study with Furosemide, Piretanide, and Ramipril in Spontaneously Hypertensive Rats

Preservation of Endothelial Function by Ramipril in Rabbits on a Long-Term Atherogenic Diet

CE Inhibition and Natriuresis with Ramipril in Conscious SHR: Different Modes of Action of Loop and Thiazide Diuretics

Nephroprotection by long-term ACE inhibition with ramipril in spontaneously hypertensive stroke prone rats

High-Affinity Binding of the Converting Enzyme Inhibitor, Ramiprilat, to Isolated Human Glomeruli

Efficacy and safety of once weekly subcutaneous idrabiotaparinux in the treatment of patients with symptomatic deep venous thrombosis

Sustained Diurnal Blood Pressure Reduction in SHR with Ramipril Assessed by Telemetric Monitoring

Suchergebnisse filtern